Zai Lab (ZLAB) Operating Expenses (2018 - 2026)
Zai Lab (ZLAB) posted Operating Expenses of $130.7 million for Q1 2026, down 2.98% sequentially from $134.7 million in Q4 2025, and up 5.24% YoY from $124.2 million in Q1 2025.
Zai Lab (ZLAB) Operating Expenses (2018 - 2026) Analysis & Trends
Zai Lab has reported Operating Expenses for 9 years, with the latest figure at $130.7 million in Q1 2026.
- Quarterly Operating Expenses rose 5.24% year-over-year to $130.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $505.0 million (down 5.35% YoY) and the FY2025 annual result came in at $498.5 million, down 6.51% from the prior year.
- Operating Expenses retreated to $130.7 million in Q1 2026 per ZLAB's latest filing, from $134.7 million in the prior quarter.
- Over five years, Operating Expenses peaked at $166.1 million in Q3 2022 and troughed at $110.8 million in Q1 2022.
- A 5-year average of $132.7 million and a median of $130.7 million in 2026 frame the typical range for Operating Expenses.
- The widest YoY moves for Operating Expenses: up 45.5% in 2022, down 53.75% in 2022.
- Over 5 years, Operating Expenses stood at $139.0 million in 2022, then grew by 18.42% to $164.6 million in 2023, then decreased by 18.05% to $134.9 million in 2024, then dropped by 0.15% to $134.7 million in 2025, then declined by 2.98% to $130.7 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $130.7 million, $134.7 million, and $118.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn | 134.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 134.64 Mn |
| Mar 31, 2026 | 130.66 Mn |
| Dec 31, 2025 | 134.67 Mn |
| Sep 30, 2025 | 118.03 Mn |
| Jun 30, 2025 | 121.65 Mn |
| Mar 31, 2025 | 124.15 Mn |
| Dec 31, 2024 | 134.87 Mn |
| Sep 30, 2024 | 133.20 Mn |
| Jun 30, 2024 | 141.34 Mn |
| Mar 31, 2024 | 123.84 Mn |
| Dec 31, 2023 | 164.57 Mn |
| Sep 30, 2023 | 127.32 Mn |
| Jun 30, 2023 | 144.60 Mn |
| Mar 31, 2023 | 110.98 Mn |
| Dec 31, 2022 | 138.97 Mn |
| Sep 30, 2022 | 166.08 Mn |
| Jun 30, 2022 | 129.49 Mn |
| Mar 31, 2022 | 110.85 Mn |
| Dec 31, 2021 | 241.66 Mn |
| Sep 30, 2021 | 114.15 Mn |